Attenuated replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron
… virus remains unknown. Here we show that the replication of Omicron is substantially attenuated
in … -type SARS-CoV-2 (HKU-001a) and previous variants, which may explain its reduced …
in … -type SARS-CoV-2 (HKU-001a) and previous variants, which may explain its reduced …
[HTML][HTML] Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission
… influence of ORF8 on replication in the context of a full replicating SARS-CoV genome, based
… We find that the 29 nt deletion conferred an attenuation of replication level irrespective of …
… We find that the 29 nt deletion conferred an attenuation of replication level irrespective of …
[HTML][HTML] Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice
… These data support development of VSV-SARS-CoV-2 as an attenuated, replication-…
SARS-CoV-2. Because of this data, we hypothesized that a replicating VSV-eGFP-SARS-CoV-2 …
SARS-CoV-2. Because of this data, we hypothesized that a replicating VSV-eGFP-SARS-CoV-2 …
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
… attenuated SARS-CoV-2 (with deleted accessory proteins and rewired TRS) that can potentially
serve as a live-attenuated … ∆3a in viral attenuation, we compared the replication kinetics …
serve as a live-attenuated … ∆3a in viral attenuation, we compared the replication kinetics …
The reassessed potential of SARS-CoV-2 attenuation for COVID-19 vaccine development—A systematic review
M Goławski, P Lewandowski, I Jabłońska, M Delijewski - Viruses, 2022 - mdpi.com
… Based on the arguments presented in Section 3, FCS deletion appears to be the best
strategy for achieving an attenuated but replicating SARS-CoV-2 vaccine. This finding is …
strategy for achieving an attenuated but replicating SARS-CoV-2 vaccine. This finding is …
Strong attenuation of SARS-CoV-2 Omicron BA. 1 and increased replication of the BA. 5 subvariant in human cardiomyocytes
R Nchioua, F Diofano, S Noettger… - … and Targeted Therapy, 2022 - nature.com
… Our finding that BA.1 is strongly attenuated in iPSC-derived … and cardiomyopathies compared
to other SARS-CoV-2 VOCs. … of attenuated forms of BA.5 and future SARS-CoV-2 variants. …
to other SARS-CoV-2 VOCs. … of attenuated forms of BA.5 and future SARS-CoV-2 variants. …
A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters
X Liu, C Luongo, Y Matsuoka… - Proceedings of the …, 2021 - National Acad Sciences
… a vectored SARS-CoV-2 vaccine candidate for intranasal immunization of infants and young
children. The vaccine is based on an attenuated, replication-competent parainfluenza virus …
children. The vaccine is based on an attenuated, replication-competent parainfluenza virus …
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA. 1 variant through NSP6
… critical attenuating mutations, which dampen viral RNA replication and … SARS-CoV-2
replication and reveals deficits in nonstructural protein function underlying Omicron attenuation…
replication and reveals deficits in nonstructural protein function underlying Omicron attenuation…
[HTML][HTML] The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
… SARS-COV-2 has recently emerged as a new public health threat. Herein, we report that
the FDA-approved drug, auranofin, inhibits SARS-COV-2 replication … expression of SARS-COV-…
the FDA-approved drug, auranofin, inhibits SARS-COV-2 replication … expression of SARS-COV-…
SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium
AC Sims, SE Burkett, B Yount, RJ Pickles - Virus research, 2008 - Elsevier
… for wild type and attenuated respiratory viruses in the … live attenuated respiratory virus
vaccine replication and pathogenicity in the human lung prior to phase one trials. Live attenuated …
vaccine replication and pathogenicity in the human lung prior to phase one trials. Live attenuated …
相关搜索
- sars cov 2 omicron
- sars cov 2 variants
- sars cov omicron variant
- sars cov vesicular stomatitis virus
- sars cov syrian hamsters
- sars cov 2 spike protein
- sars cov 2 vaccine
- sars cov vaccine candidate
- sars cov hamster model
- sars cov nonhuman primates
- sars cov tropism shift
- sars cov 2 infection
- sars cov mice and hamsters
- sars cov intranasal vaccine
- sars cov omicron subvariants
- sars cov systematic review